Articles On Recce Pharmaceuticals (ASX:RCE)

Title Source Codes Date
Things you may not know about Made in Australia, and ASX stocks that manufacture right here

Albanese govt announces the Future Made in Australia Act Why supporting Australian Made is a win-win game Stockhead reached out to Australian Made CEO, Ben Lazzaro   The ambitiously named Future Made in Australia Act was launched a couple...

Stockhead RCE 1 day ago
Market Close: ASX resurfaces with a brighter smile on its dial

The ASX200 closed the day up more than a per cent (1.08%). All sectors bar one finished in the green. Energy fell 1.5 per cent, but Healthcare lead gains, nearly two per cent (1.97%). Telecommunications followed, up 1.7 per cent. In t... RCE 1 day ago
Recce weighs in on Q1 2024 as cash increases 100%

Recce Pharmaceuticals (ASX:RCE), developing a body of anti-infective drugs for Australian and international markets, posted the results of its latest quarterly on Monday. The company wound up March with $8.5M in cash; an increase of arou... RCE 2 days ago
Market Update: ASX slides deeper on a slippier than expected slope

The ASX200 has shed nearly double what futures predicted, trading down 2.05% All 11 sectors are in the red. Discretionary has lost the most so far, down 2.6%. Real Estate follows, down 2.305%, while in Canberra supermarket executives saw... RCE 1 week ago
Recce Pharmaceuticals up 6% on new antibiotic production milestone

Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards. What it means is its patented manufacturing p... RCE 1 week ago
Research To Download: Pharma & Biotech, Bowen Coking Coal, Fluence, Ricegrowers, & More

Research reports on ASX-listed companies, to download in full. **** -Amaero International ((3DA)) by Research as a Service (RaaS): -Argo Global Listed...

FNArena RCE 2 weeks ago
Recce gearing up for Indonesian trials; US DOD looking at R327 burn gel

Recce Pharmaceuticals (ASX:RCE) published a business update highlighting two key developments with the potential to deliver share price upside on Monday. Firstly, Recce is stepping up its trial activities in Australia’s nearest Asian nei... RCE 2 weeks ago
Market update: ASX takes a breather from all time high summit

The ASX200 is trading down around 1.19 per cent, taking a slight respite from yesterday’s all-time high. Most sectors are in the red, IT has dropped the most, down nearly four per cent. Real estate follows and is down around 3.1 per cent... RCE 3 weeks ago
Recce Pharmaceuticals inks new patent for flagship drug in Israel

Recce Pharmaceuticals (ASX:RCE) has successfully obtained its first patent for its flagship anti-infective drug R327 in Israel. The State of Israel Patent Office ticked off on patent #295116 under ‘Patent Family 4.’ The patent expires in... RCE 3 weeks ago
Market Close: ASX200 posts strong green run as Fed reaffirms rate cut trajectory

The ASX200 had a stellar run on Thursday, closing up more than one point ten per cent.  All sectors except healthcare and utilities finished in the green. The financials sector led the pack at close, finishing one and three quarters p... RCE 1 month ago
Market Update: Financials lead index to record territory

The ASX200 has run up 1.16 per cent to be trading in record territory at 7,785 points. All sectors, except Healthcare are in the green. Financials lead the gains, up more than 1.6 per cent. Real estate is following closely up about 1.4 p... RCE 1 month ago
Recce Pharmaceuticals secures Trademark Registration in Canada

Recce Pharmaceuticals (ASX: RCE), who has been pioneering a new class of synthetic anti-infectives, has secured a Trademark Registration for RECCE® by the Canadian Intellectual Property Office. The International Trademark Registration No... RCE 1 month ago
Market Update: Brent prices save Energy sector from a sea of red

The ASX200 has traded down well over a per cent this morning – performing worse than predicted. All sectors, except Energy and Real Estate, have been in the red, with Materials shedding more than 2 per cent. Utilities is also making smal... RCE 1 month ago
Recce reaches testing milestone for UTI, Uroseptis antibiotic

Recce Pharmaceuticals Limited (ASX: RCE) has completed tests involving a four-person cohort for its RECCE 327 (R237) synthetic antibiotic, which will be used to treat urinary tract infection (UTI) and urosepsis. The four subjects were do... RCE 1 month ago
Market Update: Good news for landlords boosts Real Estate sector

There was good news for those with property investments today… the median price of a house in Australia has gone up to $933,800 – that’s a rise of $13,400 in just one quarter. Not such good news for those trying to invest in property, as... RCE 1 month ago
Recce Pharma (ASX:RCE) kicks-off dosing for next cohort of UTI trial

Recce Pharmaceuticals (ASX: RCE) (FSE: R9Q) announces the successful dosing of the latest group of human participants with RECCE 327 (R327) Administered intravenously at a rate of 20 minutes and a dosage of 3,000mg RCE last traded at... RCE 1 month ago
Market Close: Financials rocket while records fall

The weekend begins after a day of record breaking on the ASX. The ASX200 closed well over a per cent up at 7847 points, after peaking at 7453 points earlier in the session. The All Ordinaries – Australia’s index of the largest 500 compan... RCE 1 month ago
Recce Pharmaceuticals secures AUD$11.18M from Endpoints Capital

Recce Pharmaceuticals announces the receipt of an AUD$11,178,965 R&D Advance from Endpoints Capital Agreement allows Endpoints, a SEC-registered investment advisor, to capture Recce’s Research and Development (R&D) tax incentive... RCE 1 month ago
Research To Download: Bell Financial, Cash Converters, EML Payments, Freelancer, & More!

Research reports on ASX-listed companies, to download in full. **** -Actinogen Medical ((ACW)) by Edison Research: -Amaero International ((3DA)) by Re...

FNArena RCE 1 month ago
ASX Large Caps: Coles takes lead as iron ore miners struggle; Bitcoin nears US$56k

ASX closed flat, as Coles-led Staples sector gained Iron ore stocks under pressure as iron ore futures continue to fall Bitcoin now nearly at US$56k   The ASX 200 closed +0.13% higher on Tuesday, as gains in Consumer Staples were offset b...

Stockhead RCE 1 month ago
Market Update: Consumer staples best performer on Coles’ results

The ASX200 has been trading fairly flat, having headed down about .2 per cent earlier in the session. The drags have included the Real Estate sector, materials and communications. However, consumer staples has led the day so far, up n... RCE 1 month ago
Why Coles, G8 Education, Helia, and Reece shares are storming higher

The S&P/ASX 200 Index (ASX: XJO) has followed Wall Street's lead and dropped into the red. In afternoon trade, the benchmark index is down 0.25% to 7,633.2 points. Four ASX shares that are not letting that hold them back are listed b...

Motley Fool RCE 1 month ago
Recce Pharmaceuticals leads the way in collaborative Anti-Infective research

Recce Pharmaceuticals (ASX:RCE) highlights ongoing initiatives within its Anti-Infective Research (AIR) Unit situated at the Murdoch Children’s Research Institute (MCRI), Victoria The collaboration has been crucial in delivering positive... RCE 1 month ago
ASX Health Stocks: Recce, Cynata say their diabetic foot ulcer trials are going great guns

Recce Pharma says Phase 1/2 study is achieving primary endpoints Cynata also reports also reports good progress in Phase 1 Cardiex is back on the ASX!   Recce to expand diabetes foot ulcer Phase 1/2 trial An independent Safety Committee h...

Stockhead RCE 1 month ago
Recce Pharmaceuticals wins safety approval to expand wound infection trial

Recce Pharmaceuticals’ (ASX:RCE) flagship product is a versatile drug called R327 It can be used as a gel to treat wound infections The company is investigating on patients with Diabetes suffering post-surgery complications Share... RCE 1 month ago
Recce Pharmaceuticals signs MoU with Indonesian partner to progress anti-infectives

Recce Pharmaceuticals (ASX:RCE) has signed a Memorandum of Understanding with Indonesian organisation PT Etana Biotechnologies to accelerate the development of the Australian company's anti-infective portfolio.

BiotechDispatch RCE 2 months ago
TMH Market Update: Origin Energy’s takeover bid faces late hurdles; TPG Telecom boosts 5G

We’re here for day two of the RIU Resurgence conference in Perth, and it’s certainly busy here with investors, brokers and a host of uranium, batteries metals and gold companies too. The ASX200 is trading down more than half a per cent w... RCE 5 months ago
Recce Pharmaceuticals wins Canadian patent for flagship anti-infectives

Recce Pharmaceuticals (ASX:RCE) develops anti-infectives for a range of issues and post-surgical complications The company has now won a patent in Canada Its lead drug R327 is both injectable and applicable as a gel Shares last t... RCE 5 months ago
TMH Market Close: RBA lifts cash rate to 4.35pc, ASX200 dips

Shortly before Without A Fight crossed the finish line to win the 2023 Melbourne Cup, the Reserve Bank of Australia lifted the cash rate once again – by 25 basis points to 4.35 per cent for November. The decision was in line with expert... RCE 5 months ago
TMH Market Update: RBA lifts interest rates to 4.35pc on Melbourne Cup Day

The Reserve Bank of Australia has decided to lift the cash rate again — upping it by 25 basis points to 4.35 per cent for November. It’s the 13th raise in only 16 months and follows the nation’s latest inflation data released just two w... RCE 5 months ago
Recce Pharmaceuticals doses first patients over 15 minutes in R327 UTI/urosepsis trial

Recce Pharmaceuticals (ASX:RCE) completes dosing of the first male and female subjects in its UTI/urosepsis clinical trial at the highest concentration of R327 The dosing lasts 15 minutes at 3000mg and was approved by an independent safe... RCE 5 months ago
TMH Market Close: Bitcoin surges as investors anticipate ETF launch

The ASX200 lifted nearly 0.2 of a per cent by the end of the day’s session, with materials taking a late run to gain .8 of a per cent. Energy also added almost half a per cent.   Cryptocurrency Bitcoin has also jumped almost 10 per cent... RCE 5 months ago
Recce Pharmaceuticals accelerates R327 trial for UTI patients with faster infusion rate approval

Recce Pharmaceuticals (ASX:RCE) UTI trial using flagship anti-infective R327 has been greenlit to go further The company can now dose patients 3000mg in an IV transfusion of 15 minutes RCE continues to compile safety data around IV... RCE 6 months ago
ASX Health Stocks: Recce moves forward in Phase 1/2 study; EMV unveils Gen 2 helmet scanner for ambulance

Recce Pharma moves forward to stronger dose in Phase 1/2 trial EMV is bench testing its 2nd Gen ultra-light weight helmet scanner   Recce Pharma moves forward to higher dosage Synthetic anti-infectives producer, Recce Pharmaceuticals (ASX...

Stockhead RCE 6 months ago
TMH Market Update: Liontown shares fall on raise to fund Kathleen Valley operation

The ASX200 is down nearly 1.2 percent with most sectors in the red. Energy is the only sector making gains, up just over a third of a per cent.   Liontown Resources (ASX:LTR) has taken a dive, now down nearly 30 per cent after raising $3... RCE 6 months ago
Recce Pharmaceuticals ends September quarter with $8m in cash with busy 2024 ahead

Recce Pharmaceuticals (ASX:RCE) winds up the September quarter with $8 million in cash The company has registered a new trademark in Vietnam Recce’s R327 trials continue to support the company’s thesis its flagship anti-infective is... RCE 6 months ago
Recce Pharmaceuticals raise to progress advanced anti-infective

Sonia Madigan: Recce Pharmaceuticals (ASX:RCE) has raised $11 million to continue developing its late-stage drug candidate, anti-infective, R327. Why did the company raise now? RCE CEO, James Graham, is here to explain. James Graham:... RCE 6 months ago
Recce Pharmaceuticals advances anti-infective development and clinical trials in FY23

Recce Pharmaceuticals (ASX:RCE) is fast-tracking the development of its synthetic class of potent anti-infectives, with significant progress being made in FY23 In FY23, the Anti-Infective Research Unit at the Murdoch Children’s Research... RCE 6 months ago
TMH Market Close: ASX200 closes higher; News Corp shares rise as Murdoch succession finally plays out

The ASX200 ended the week up just, despite the week’s losses totalling more than one and half per cent. Utilities, energy and materials led the gains, while real estate was today’s worst performer, down almost 1.5 per cent. In the gr... RCE 7 months ago
TMH Market Update: New Qantas CEO apologises, but will it land?

Whilst the ASX200 has slipped .6 of a per cent, that performance is considerably better than futures suggested.  Real estate and health care are the key drags on the market today, losing almost 1 and a half per cent each, while consumer... RCE 7 months ago
Recce Pharmaceuticals (ASX:RCE) completes cohort dosing in UTI rapid infusion trial

Recce Pharmaceuticals (RCE) completes dosing its male and female subjects in its phase I/II UTI clinical trial with Scientia Research The trial evaluates R327 anti-infective at faster infusion rates of 30 minutes at a dosage of 3000mg, w... RCE 7 months ago
Recce Pharmaceuticals (ASX:RCE) paves its way to commercialisation with breakthrough antibiotic, R327

Treatment for infectious diseases continues to pose a significant threat to populations worldwide, with the effectiveness of many anti-infective medications lost to antimicrobial resistance (AMR).  However, in this current era where conc... RCE 7 months ago
Research To Download: Actinogen, De.mem, Quantm, Spartan, & Others

Research reports on ASX-listed companies, to download in full. **** –Actinogen Medical ((ACW)) by Edison Research: –AFT Pharmaceuticals ((AFP)) by Edi...

FNArena RCE 7 months ago
Global fund takes stake in Recce as synthetic antibiotic developer raises $11m

Recce Pharmaceuticals (ASX: RCE), a company developing a new class of synthetic antibiotics, is raising $11 million to boost its research program, bolster manufacturing capabilities and expand further into the US. The Sydney-based company,... RCE 7 months ago
TMH Market Close: ASX200 edges higher as big four banks register gains

The ASX200 gradually climbed today to gain close to half a per cent. Financials registered the highest gains, up nearly 1.3 per cent With that, the big four banks NAB, CBA, Westpac and ANZ all gained around a per cent. Healthcare, on... RCE 7 months ago
Why is the Recce Pharmaceuticals share price collapsing 26% today?

The Recce Pharmaceuticals Ltd (ASX: RCE) share price has returned from a trading halt and crashed deep into the red. In afternoon trade, the pharmaceutical company's shares are down 26% to 48 cents. Why is the Recce Pharmaceuticals share p...

Motley Fool RCE 7 months ago
Recce Pharmaceuticals (ASX:RCE) taps investors for up to $11m to drive anti-infective trials and US expansion

Recce Pharmaceuticals (RCE) is raising up to $11 million through a strongly supported placement and entitlement offer The placement comprises the issuance of 18.2 million new shares at 44 cents each Funds will be used toward further t... RCE 7 months ago
Closing Bell: Benchmark ends lower, loses 2.2% for the week. China jitters, I suppose. It’s unpleasant to report and I’m not proud.

ASX 200 closes about 0.3% lower, down well over 2.2% for the week. Materials and Consumer discretionary weigh, Healthcare rises. Small caps led by Oliver’s Real Foods, which has leapt mightily despite having no fresh news.   The Aussie...

Stockhead RCE 7 months ago
TMH Market Update: Chevron strikes threaten global LNG supply

The ASX200 has traded down about point four of a per cent this morning.  Sector performances varied, with utilities leading with a gain of .7 per cent, while materials stocks shed just shy of a per cent.  Mining giants BHP, FMG and Ri... RCE 7 months ago
TMH Market Update: ASX slips, energy bucks the trend

The Australian stock market has dropped more than three-quarters of a per cent in the first hours of trade. Energy has been the only sector in the green after oil-producing nations vowed to continue limiting supply. Energy has been up we... RCE 7 months ago